I hope this doesn't sound callous, but is there anything (beyond pancreatic cancer's aggressive mortality rate) to suggest that the disease is somehow "ripe" for increased research funding?

"How much money should we spend on cancer research?" has been in the HN aether lately, so I'm curious.